Century Therapeutics (IPSC) executive compensation, 2026 proxy

Brent Pfeiffenberger, President, Chief Executive Officer and Chairman of the Board, was paid $2.4M in 2025, up 9% from $2.2M the year before.

Filed
April 27, 2026
Annual meeting
June 11, 2026
Pay year
2025
Named executives
4
CEO total pay
$2.4M+9% vs prior year
CEO pay in equity
88%$2.1M in awards
CEO Target Bonus
55%Percentage of base salary
2025 Bonus Payout
90%Achievement level for corporate goals
CEO Retention Award
1,587,614Granted in August 2025

How Pfeiffenberger was paid

$2.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Brent PfeiffenbergerPresident, Chief Executive Officer and Chairman of the Board$2,381,022
Gregory RussottiChief Technology and Manufacturing Officer$912,320
Adrienne FaridFormer Chief Development Officer$989,403
Chad CowanChief Scientific Officer$1,167,015

What changed and why

  • $2.4MCEO total compensation increased to $2,381,022 in 2025 from $2,193,281 in 2024.
  • $644KCEO base salary was set at $643,800 effective March 1, 2025.
  • 90%Corporate goals for 2025 annual bonuses were achieved at 90%.
  • CEO received a retention award of 1,587,614 RSUs in August 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.